627 related articles for article (PubMed ID: 25003359)
61. Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
Strader CR; Pearce CJ; Oberlies NH
J Nat Prod; 2011 Apr; 74(4):900-7. PubMed ID: 21456524
[TBL] [Abstract][Full Text] [Related]
62. Effects of fingolimod in relapsing-remitting multiple sclerosis.
Sorensen PS
Lancet Neurol; 2014 Jun; 13(6):526-7. PubMed ID: 24685277
[No Abstract] [Full Text] [Related]
63. Cardiac and vascular effects of fingolimod: mechanistic basis and clinical implications.
Camm J; Hla T; Bakshi R; Brinkmann V
Am Heart J; 2014 Nov; 168(5):632-44. PubMed ID: 25440790
[TBL] [Abstract][Full Text] [Related]
64. Siponimod (BAF-312) Attenuates Perihemorrhagic Edema And Improves Survival in Experimental Intracerebral Hemorrhage.
Bobinger T; Manaenko A; Burkardt P; Beuscher V; Sprügel MI; Roeder SS; Bäuerle T; Seyler L; Nagel AM; Linker RA; Engelhorn T; Dörfler A; Horsten SV; Schwab S; Huttner HB
Stroke; 2019 Nov; 50(11):3246-3254. PubMed ID: 31558140
[TBL] [Abstract][Full Text] [Related]
65. Recognizing and overcoming potential barriers to oral medications for MS.
Moses H
J Clin Psychiatry; 2014 Oct; 75(10):e28. PubMed ID: 25373133
[TBL] [Abstract][Full Text] [Related]
66. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].
Komoly S
Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178
[No Abstract] [Full Text] [Related]
67. No exacerbation of perihematomal edema with intraclot urokinase in patients with spontaneous intracerebral hemorrhage.
Lian L; Xu F; Hu Q; Liang Q; Zhu W; Kang H; Liu X; Tang Z; Zhu S
Acta Neurochir (Wien); 2014 Sep; 156(9):1735-44. PubMed ID: 24861986
[TBL] [Abstract][Full Text] [Related]
68. [Infections and fingolimod].
Cervera C
Rev Neurol; 2012 Aug; 55(4):227-37. PubMed ID: 22829086
[TBL] [Abstract][Full Text] [Related]
69. Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy.
Ingwersen J; Aktas O; Kuery P; Kieseier B; Boyko A; Hartung HP
Clin Immunol; 2012 Jan; 142(1):15-24. PubMed ID: 21669553
[TBL] [Abstract][Full Text] [Related]
70. Fingolimod.
Prescrire Int; 2011; 20(118):173-4, 176-7. PubMed ID: 21751747
[TBL] [Abstract][Full Text] [Related]
71. Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage.
Lu L; Barfejani AH; Qin T; Dong Q; Ayata C; Waeber C
Brain Res; 2014 Mar; 1555():89-96. PubMed ID: 24502984
[TBL] [Abstract][Full Text] [Related]
72. Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging.
Venkatasubramanian C; Mlynash M; Finley-Caulfield A; Eyngorn I; Kalimuthu R; Snider RW; Wijman CA
Stroke; 2011 Jan; 42(1):73-80. PubMed ID: 21164136
[TBL] [Abstract][Full Text] [Related]
73. Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease.
Raveney BJ; Copland DA; Nicholson LB; Dick AD
Arch Ophthalmol; 2008 Oct; 126(10):1390-5. PubMed ID: 18852417
[TBL] [Abstract][Full Text] [Related]
74. Peri-hematomal edema shape features related to 3-month outcome in acute supratentorial intracerebral hemorrhage.
Dierksen F; Tran AT; Zeevi T; Maier IL; Qureshi AI; Sanelli PC; Werring DJ; Malhotra A; Falcone GJ; Sheth KN; Payabvash S
Eur Stroke J; 2024 Jun; 9(2):383-390. PubMed ID: 38179883
[TBL] [Abstract][Full Text] [Related]
75. Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier.
Copland DA; Liu J; Schewitz-Bowers LP; Brinkmann V; Anderson K; Nicholson LB; Dick AD
Am J Pathol; 2012 Feb; 180(2):672-81. PubMed ID: 22119714
[TBL] [Abstract][Full Text] [Related]
76. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.
Arvin AM; Wolinsky JS; Kappos L; Morris MI; Reder AT; Tornatore C; Gershon A; Gershon M; Levin MJ; Bezuidenhoudt M; Putzki N
JAMA Neurol; 2015 Jan; 72(1):31-9. PubMed ID: 25419615
[TBL] [Abstract][Full Text] [Related]
77. [Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Fernández Ó; Rodríguez-Antigüedad A; Oreja-Guevara C; Garcia-Garcia M; Montalban X;
Rev Neurol; 2014 Jan; 58(2):77-83. PubMed ID: 24399624
[TBL] [Abstract][Full Text] [Related]
78. The Hounsfield Unit of Perihematomal Edema Is Associated With Poor Clinical Outcomes in Intracerebral Hemorrhage.
Huan R; Li Y; Tan J; Tang J; Huang N; Cheng Y
World Neurosurg; 2021 Feb; 146():e829-e836. PubMed ID: 33189917
[TBL] [Abstract][Full Text] [Related]
79. Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage.
Delgado P; Cuadrado E; Rosell A; Alvarez-Sabín J; Ortega-Aznar A; Hernández-Guillamón M; Penalba A; Molina CA; Montaner J
Stroke; 2008 Jun; 39(6):1730-4. PubMed ID: 18403741
[TBL] [Abstract][Full Text] [Related]
80. Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis.
Kappos L; Mehling M; Arroyo R; Izquierdo G; Selmaj K; Curovic-Perisic V; Keil A; Bijarnia M; Singh A; von Rosenstiel P
Neurology; 2015 Mar; 84(9):872-9. PubMed ID: 25636714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
